The research shows that these immune changes can appear up to a year before a cancer diagnosis, opening new possibilities for early detection.
Read moreUn estudio que presenta una nueva inmunoterapia celular para mejorar el tratamiento de la leucemia linfoblástica aguda de células B (B-ALL), del que son autores investigadores del Centro Nacional de...
Read moreOn December 1, World AIDS Day, Clínic Barcelona highlights the importance of maintaining global efforts to control and eventually eradicate HIV — a pandemic that still affects millions of people...
Read moreEl Hospital del Mar lidera, con la Subdirección General de Adicciones, VIH, Infecciones de Transmisión Sexual y Hepatitis Víricas del Departament de Salut, un proyecto para administrar directamente...
Read moreResearchers from the Biomarkers of Cardiovascular Disease Progression group at the Institut de Recerca Sant Pau (IR Sant Pau) have identified a new mechanism by which complement C3, a key immune syste...
Read moreFrom cancer research to neurodegenerative diseases, their partner, LifeSensors offers a wide range of technologies for ubiquitination, targeted protein degradation (TPD), PROTACs, molecular glues and ...
Read moreThe Centre for Genomic Regulation is participating in a new European research initiative that will explore why some wild African suid species can withstand African swine fever (ASF) while domestic pig...
Read moreEl congreso CNIO-CaixaResearch Frontiers Meetings reúne múltiples disciplinas que colaboran para abordar las enfermedades asociadas a la edad, cada vez más prevalentes
Read moreAn international team has published NeuMap, the first atlas to reveal the global architecture of neutrophils, showing how this “first line of defense” reorganizes to protect, remember, and heal.
Read moreThis study opens the door to a new strategy to sensitize this subtype of breast cancer to immunotherapy.The goal is to work towards turning this modified LCOR into a therapy that can be investigated i...
Read morePor primera vez en Cataluña fuera de un ensayo clínico, una persona con un sistema inmunitario hiperactivado ha podido recibir un riñón gracias a la imlifidasa. Se trata de pacientes hipersensibil...
Read moreLa administración de butirato en modelos de ratones, combinada con la inmunoterapia, alargó su supervivencia
Read more